We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
- Authors
Rerks-Ngarm, Supachai; Paris, Robert M; Chunsutthiwat, Supamit; Premsri, Nakorn; Namwat, Chawetsan; Bowonwatanuwong, Chureeratana; Li, Shuying S; Kaewkungkal, Jaranit; Trichavaroj, Rapee; Churikanont, Nampueng; de Souza, Mark S; Andrews, Charla; Francis, Donald; Adams, Elizabeth; Flores, Jorge; Gurunathan, Sanjay; Tartaglia, Jim; O'Connell, Robert J; Eamsila, Chirapa; Nitayaphan, Sorachai; Ngauy, Viseth; Thongcharoen, Prasert; Kunasol, Prayura; Michael, Nelson L; Robb, Merlin L; Gilbert, Peter B; Kim, Jerome H
- Abstract
The Thai Phase III Trial of ALVAC-HIV and AIDSVAX B/E showed an estimated vaccine efficacy (VE) of 31% to prevent acquisition of human immunodeficiency virus (HIV). Here we evaluated the effect of vaccination on disease progression after infection.
- Publication
The Journal of infectious diseases, 2013, Vol 207, Issue 8, p1195
- ISSN
1537-6613
- Publication type
Journal Article
- DOI
10.1093/infdis/jis478